10-Q/A XBRL

10-Q/A Filing

Company: Marker Therapeutics, Inc.
Filed: August 19, 2013
Period of Report: March 31, 2013
Accession Number: 0001424884-13-000037

View Document ↗ View on SEC.gov ↗